Literature DB >> 200309

A morphine-like factor in mammalian brain: analgesic activity in rats.

A Pert, R Simantov, S H Snyder.   

Abstract

A partially purified morphine-like peptide 'enkephalin' (PPE) extract from bovine brain elicited pronounced apparent analgesia after injection into the periaqueductal gray matter of rat brain. This analgesia was reversed by the opiate antagonist naloxone in a dose-dependent fashion. Analgesia was more rapid in onset and much shorter in duration after PPE than after morphine administration. Analgesia was elicited only by those ion exchange column fractions of PPE that competed potently for opiate receptor binding. No analgesia could be detected when PPE or morphine injections were administered at a site 2 mm lateral to the periaqueductal gray matter. The potencies of synthetic methionine- and leucine-enkephalin in eliciting analgesia were less than 1% of those of partially purified enkephalin extracts when doses of equivalent ability to compete for opiate receptor binding were compared.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200309     DOI: 10.1016/0006-8993(77)90076-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  High molecular weight opioid-containing proteins in striatum.

Authors:  R V Lewis; S Stein; L D Gerber; M Rubinstein; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

Review 2.  Enkephalins: Endogenous Analgesics with an Emerging Role in Stress Resilience.

Authors:  Mathilde S Henry; Louis Gendron; Marie-Eve Tremblay; Guy Drolet
Journal:  Neural Plast       Date:  2017-07-11       Impact factor: 3.599

Review 3.  Strategies for the Identification of Bioactive Neuropeptides in Vertebrates.

Authors:  Auriane Corbière; Hubert Vaudry; Philippe Chan; Marie-Laure Walet-Balieu; Thierry Lecroq; Arnaud Lefebvre; Charles Pineau; David Vaudry
Journal:  Front Neurosci       Date:  2019-09-18       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.